SELECTBIO - Bioprinting and 3D Printing in the Life Sciences Europe Keynote Speakers

Home

Agenda

Keynote Speakers

Registration

Exhibition

Venue

May Griffith

Professor and Caroline Durand Foundation Research Chair in Cellular Therapy, University of Montreal

May Griffith is Professor of Ophthalmology at the University of Montreal, and holds the Caroline Durand Foundation Research Chair in Cellular Therapy. She is also a co-founder of UAB Ferentis, an award-winning start-up spun off from the EuroNanomedicine project “I-CARE”. MG’s current research is in the development of biomimetic materials based on collagen and its analogs, for translational regenerative medicine applications. She has led a team that developed the world's first cell-free corneal implants that successfully promoted regeneration of corneal tissues and nerves. She continues to work on improvements for use in corneas with more severe pathologies that are currently deemed not treatable, by developing new materials, incorporation of nano-delivery systems and surface patterning techniques. The biomaterials developed are also being tested for use in theranostics, and as pro-regeneration scaffolds in other organ systems in collaboration with other researchers.

James Hickman

Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos

James J. Hickman is the Founding Director of the NanoScience Technology Center and a Professor of Nanoscience Technology, Chemistry, Biomolecular Science, Biomedical Engineering, Material Science and Electrical Engineering at the University of Central Florida. Previously, he held the position of the Hunter Endowed Chair in the Bioengineering Department at Clemson University. Dr. Hickman has a Ph.D. from the Massachusetts Institute of Technology in Chemistry. For the past thirty years, he has been studying the interaction of biological species with modified surfaces, first in industry and in the latter years in academia. While in industry he established one of the first bioelectronics labs in the country that focused on cell-based sensors and their integration with electronic devices and MEMS devices. He is interested in creating hybrid systems for biosensor and biological computation applications and the creation of functional in vitro systems for human body-on-a-chip applications. He has worked at NSF and DARPA in the area of biological computation. He is also the founder and current Chief Scientist of a biotechnology company, Hesperos, that is focusing on cell-based systems for drug discovery and toxicity. He has 166 publications and 20 book chapters, in addition to 34 issued patents out of 50 total patent applications. He was elected to the Board of Directors of the American Institute for Medical and Biological Engineering (AIMBE) for 2 consecutive terms, the premier society for Biomedical Engineering of which he is a Fellow. He is also a Fellow of the American Vacuum Society (AVS) and National Academy of Inventors (NAI) as well as BioFlorida’s Researcher of the Year (2022). Dr. Hickman along with Dr. Michael Shuler, won the Lush Prize, in the Science Category, which Supports Animal Free Testing in 2015.

Yan Yan Shery Huang

Professor of BioEngineering, University of Cambridge

Dr. Huang is Professor of BioEngineering, University of Cambridge. She completed her MEng degree in Materials Science and Engineering from Imperial College London in 2007. She then pursued a PhD in Physics at Cambridge. She was a visiting researcher at University of Texas at Austin (2008), and an Oppenheimer Fellow and a Homerton College Junior Research Fellow (2011-2013). She is a recipient of the prestigious ERC Starting grant, and a fellow of the Institute of Fellow of the Institute of Materials, Minerals and Mining, UK.

Clive Roberts

Professor of Pharmaceutical Nanotechnology and Head of School of Pharmacy, University of Nottingham

Clive Roberts is Professor of Pharmaceutical Nanotechnology at the School of Pharmacy, University of Nottingham. He graduated in physics from Imperial College in 1987, receiving a PhD in surface physics, also from Imperial College in 1991. He is currently Head of the School of Pharmacy and in the past has been a Director of the Nottingham Nanotechnology Centre (2007-2013). His research is focussed on improving methods to develop new medicines, which has led to over 270 research publications. He has been actively involved in the organization of major public understanding of science events focussed on Nanotechnology, engaging directly with tens of thousands of members of the public (nanoinNottingham, NanoWhat?, Flights of Fancy). Recently he has been involved in public exhibitions related to 3D printing of Medicines (Science Museum London, 2013-14, Manchester Science Museum 2014-2015). He was a co-founder of Molecular Profiles Limited, a successful spin-out exploiting nanotechnology based characterization in the pharmaceutical sector, which has won a number of awards including two Queen’s Award for Industry 2007/2011 and was recently acquired by Columbia Laboratories Inc. Finally, he is also one of the founders of Eminate Ltd, which develops solutions for improved health in foods, and has recently
secured two global licence deals with Tate & Lyle for its salt reduction product, SodoLoTM, a product now launched around the world.

Jürgen Stampfl

Professor, Institute of Materials Science and Technology, Vienna University of Technology

Jürgen Stampfl is professor for materials science at Vienna University of Technology. Additionally, he is head of the Christian Doppler laboratory for restorative and digital dentistry. His expertise lies in the field of lithography-based additive manufacturing technologies. He is co-founder of two start-up companies providing 3D-printing equipment and materials.